Leucine and perindopril to improve physical performance in people over 70 years with sarcopenia: the LACE factorial RCT

Background: Angiotensin-converting enzyme inhibitors and leucine are promising potential treatments for sarcopenia. Neither has yet been tested in adequately powered randomised trials in patients with sarcopenia. Objectives: To determine the efficacy of leucine and perindopril in improving physical...

Cijeli opis

Bibliografski detalji

Glavni autori:	Miles D Witham, Simon Adamson, Alison Avenell, Margaret M Band, Tufail Bashir, Peter T Donnan, Jacob George, Adrian Hapca, Cheryl Hume, Paul Kemp, Emma McKenzie, Kristina Pilvinyte, Christos Rossios, Karen Smith, Allan D Struthers, Deepa Sumukadas
Format:	Artigo
Jezik:	Inglês
Izdano:	NIHR Journals Library 2022-08-01
Serija:	Efficacy and Mechanism Evaluation
Teme:	angiotensin-converting enzyme inhibitor leucine sarcopenia randomised controlled trial
Online pristup:	https://doi.org/10.3310/LLBX6901
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!